Stockholders' Equity (Deficit) - Additional Information (Detail) - USD ($)						1 Months Ended			3 Months Ended			6 Months Ended
	May 12, 2025	Jan. 16, 2025	Jan. 02, 2025	Mar. 26, 2024	Aug. 09, 2023	May 31, 2025	Aug. 31, 2023	Jul. 31, 2023	Jun. 30, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Class of Stock [Line Items]
Common stock shares issued									1,483,738			1,483,738		696,969
Common stock shares authorized									250,000,000			250,000,000		250,000,000
Preferred stock shares authorized									20,000,000			20,000,000
Common stock, shares, outstanding									1,483,738			1,483,738		696,969
Preferred stock shares issued									0			0		0
Preferred stock shares outstanding									0			0		0
Gross proceeds from Issuance of common stock												$ 3,397,476	$ 2,687,225
Share based compensation									$ 194,323	$ 163,700		309,152	$ 375,169
Unrecognized compensation expense									$ 1,563,753			$ 1,563,753
Estimated weighted average period over which expense is expected to be recognized												2 years 7 months 6 days
AxoBio [Member]
Class of Stock [Line Items]
Stock returned and retired											128,178
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Stock returned and retired				4,243
Preferred stock shares authorized									0			0		4,243
Preferred stock shares issued									0			0		0
Preferred stock shares outstanding									0			0		0
Series A Preferred Stock [Member] | Axolotl Acquisition [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period					4,243
2023 Long-Term Incentive Plan [Member]
Class of Stock [Line Items]
Share-based compensation arrangement by share-based percentage award, award vesting rights, percentage								25.00%
Share based compensation arrangement by share based payment award maximum stock issued description												The maximum number of shares that may be issued under the 2023 Plan is the sum of: (i) 34,880, (ii) an annual increase on January 1, 2024 and each anniversary of such date prior to the termination of the 2023 Plan, equal to the lesser of (a) 4% of the outstanding shares of our Common Stock determined on a fully diluted basis as of the immediately preceding year-end and (b) such smaller number of shares as determined by the Board or the compensation committee of the Board, and (iii) the shares of Common Stock subject to 2009 Plan awards, to the extent those shares are added into the 2023 Plan by operation of the recycling provisions described below.
Stock option, vesting period								4 years
2023 Long-Term Incentive Plan [Member] | Minimum [Member]
Class of Stock [Line Items]
Percentage of stock owned by individual								10.00%
Percentage of exercise price per share from fair market value								110.00%
2023 Incentive stock option [member]
Class of Stock [Line Items]
Common stock, shares issued during the period												34,880
Share based compensation arrangement by share based payment award maximum stock issued description												The initial maximum number of shares of Common Stock that may be issued under the 2023 Plan through incentive stock options was 34,880, provided that this limit automatically increases on January 1 of each year for a period of not more than ten years, commencing on January 1, 2024 and ending on (and including) January 1, 2032, by an amount equal to the lesser of 50,000 shares or the number of shares added to the share pool as of such January 1, as described in clause (ii) of the preceding sentence.
2023 Incentive stock option [member] | Minimum [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period								50,000
Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period									479,621	44,382		748,461	44,382
Common Stock [Member] | Elevai Acquisition [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period												38,308
Number of shares issued at acquisition		38,308										38,308
Number of shares withheld at acquisition		3,927										3,927
Shares issued		$ 660,805										$ 660,805
Shares withheld		$ 67,742										$ 67,742
Common Stock [Member] | AxoBio [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period							128,178
Common Stock [Member] | Purchase Agreement [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period			268,840
Offering price			$ 6.9
Class of warrant or right, exercise price of warrants or rights	$ 3.92		$ 6.9
Common Stock Warrants [Member]
Class of Stock [Line Items]
Class of warrant or right, exercise price of warrants or rights									$ 65.6			$ 65.6		$ 303.3
Number of warrants, exercisable									707,542			707,542
Common Stock Warrants [Member] | Purchase Agreement [Member]
Class of Stock [Line Items]
Warrants to purchase number of shares of common stock			268,840
Class of warrant or right, exercise price of warrants or rights			$ 6.9
Placement Agent [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period	473,220		268,840
Placement agent fees						$ 60,000.00
Other offering expenses						$ 140,000
2025 Private Placement [Member]
Class of Stock [Line Items]
Gross proceeds from issuance of private placement			$ 1,850,000
2025 Private Placement [Member] | Purchase Agreement [Member]
Class of Stock [Line Items]
Fair value of warrant	$ 40,000.00
Placement agent fees			190,000
Other offering expenses			$ 0.3
Class of warrant or right, exercise price of warrants or rights	$ 3.92		$ 6.9
2025 Private Placement [Member] | Common Stock [Member] | Purchase Agreement [Member]
Class of Stock [Line Items]
Gross proceeds from issuance of private placement			$ 1,850,000
2025 Private Placement [Member] | Common Stock Warrants [Member] | Purchase Agreement [Member]
Class of Stock [Line Items]
Fair value of warrant			$ 310,000
Class of warrant or right, exercise price of warrants or rights			$ 6.9
Warrants and rights outstanding term			5 years
2025 Private Placement [Member] | Placement Agent [Member]
Class of Stock [Line Items]
Number of warrants issued	32,666		18,553
2025 Private Placement [Member] | Placement Agent [Member] | Common Stock Warrants [Member]
Class of Stock [Line Items]
Warrants to purchase number of shares of common stock			18,553
Warrants and rights outstanding term			5 years
ATM Financing [Member] | Common Stock Warrants and Placement Agent Warrants [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period	552,798
Number of warrants issued	38,159
Class of warrant or right, exercise price of warrants or rights	$ 3.36
ATM Financing [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares issued during the period						479,621
Gross proceeds from Issuance of common stock						$ 1,960,000
ATM Financing [Member] | Common Stock [Member] | Minimum [Member]
Class of Stock [Line Items]
Offering price						$ 3.36
ATM Financing [Member] | Common Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Offering price						4.09
ATM Financing [Member] | Common Stock [Member] | Weighted Average [Member]
Class of Stock [Line Items]
Offering price						$ 4.08